Page 13 - Broadcast Date News Today : Breaking News, Live Updates & Top Stories | Vimarsana

In this GEN webinar, Dr. Matthew Hewitt and Dr. Kimberly Negrin—experts in the field of human-derived biological products and manufacturing—will explore these distinct challenges and strategies to mitigate them. From the sheer volume of donors necessary to support cell therapy programs and the benefit of dedicated donor pools—to current testing and manufacturing gaps and the emerging solutions and processes that can increase quality, consistency, and efficiency.

In this GEN webinar, our distinguished presenters Dr. Tommy Duncan and Dr. Jill Makin, will address industry challenges and discuss an alternative to plasmid DNA—a synthetic, antibiotic-free DNA vector called dbDNA™ (doggybone DNA).

In this GEN webinar, our expert panelists will share insights on establishing a robust, automated cell manufacturing process that meets clinical and commercial demands while successfully navigating the ever-changing regulatory landscape for establishing comparability in a clinical product.

In celebration of GEN’s 40th year in publishing, GEN Live will feature a panel of biotech reporters and scientists who have been covering the bioindustry since the early 1980s. Moreover, each wrote some of their initial biotech articles for GEN just as the industry, and GEN, was taking off.

/PRNewswire/ -- Sagimet Biosciences, a clinical-stage biotechnology company, announced today that consolidated results from its Phase 2 FASCINATE-1 trial of...